A Deep Dive into Plasma Fractionation Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

What industry-specific factors are fueling the growth of the plasma fractionation market?
The surge in chronic health conditions is anticipated to catalyze the expansion of the plasma fractionation market. Chronic illnesses, generally characterised by their duration of over a year, and necessitating continuous medical supervision, like heart disease, cancer, and diabetes, when treated with plasma products, results in decreased morbidity, improved life quality and cost-effectiveness, and consequently fuels the demand for plasma fractionation. In fact, a report by the National Library of Medicine, a US-based organization, forecasts a 99.5% increase in individuals aged 50 and above with one or more chronic diseases by 2050, rising from 71.522 million in 2020 to 142.66 million in the United States. This rise in chronic disease cases is thus paving the way for the enlargement of the healthcare analytic testing service market. Therefore, the escalating number of chronic illnesses across all age groups will likely drive the growth of the plasma fractionation market.

Get Your Plasma Fractionation Market Report Here:
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Is the projected market size and growth rate for the plasma fractionation market?
The size of the plasma fractionation market has seen significant growth in the past few years. The market is expected to increase from $31.42 billion in 2024 to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The substantial growth experienced in the previous period can be credited to the escalating incidences of hemophilia and immunodeficiency disorders, an ageing population, increased demand for immunoglobulins, the expansion of plasma collection centers, and an increase in the number of surgical procedures.

In the coming years, the plasma fractionation market is predicted to witness a significant upturn, escalating to $51.56 billion in 2029 with an annual growth rate of 10.6%. Factors contributing to this estimated boom during the forecast period include increased worldwide healthcare expenditure, expanded usage of plasma-based medicinal products, heightened investment in research and development, the need for plasma in neurological disorder therapies, and the scaling up of plasma fractionation facilities. Foreseen trends for the forecasted timeframe comprise advancements in fractionation technologies, a preference shift to albumin and immunoglobulin therapies, a spike in demand for specialised plasma products, emphasis on pathogen neutralisation techniques, and strategic alliances in the plasma industry.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What new trends are reshaping the plasma fractionation market and its opportunities?
Leading firms in the industry are adopting innovative technologies, such as high-tech facilities that transform donated human plasma into vital medications. These use cutting-edge technology to increase safety and efficiency. For example, in March 2023, CSL Behring, a company based in Germany, inaugurated a new plasma fractionation facility worth $470 million. This facility leverages state-of-the-art technology to enhance the reliability and quality of plasma processing, thereby ensuring a stable supply of essential medicines. This move aims at satisfying the increasing demand and guaranteeing that more patients can access life-saving treatments. Due to its advanced automation and self-cleaning systems, the risk of contamination is reduced, thereby improving hygiene and enhancing patient safety.

What major market segments define the scope and growth of the plasma fractionation market?
The plasma fractionation market covered in this report is segmented -

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

Which region dominates the plasma fractionation market?
North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the plasma fractionation industry growth?
Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Is Covered In The Plasma Fractionation Global Market Report?

•Market Size Forecast: Examine the plasma fractionation market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the plasma fractionation market for a structured understanding.
•Key Players Overview: Analyze major players in the plasma fractionation market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the plasma fractionation market.
•Segment Contributions: Evaluate how different segments drive overall growth in the plasma fractionation market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the plasma fractionation market.
•Industry Challenges: Identify potential risks and obstacles affecting the plasma fractionation market.
•Competitive Landscape: Review strategic developments in the plasma fractionation market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.